Archive: 31/03/2014

Efforts to curb hospital readmissions take center stage

Strategies aimed at reducing the number of patients with heart failure and other cardiovascular conditions who find themselves back in the hospital after discharge were identified in six new studies presented at the American ...

Darapladib falls short in chronic coronary heart disease

The novel inflammation inhibitor darapladib showed no primary-endpoint advantage over placebo in patients with chronic coronary heart disease treated with a high level of background care, although it did suggest possible ...

page 6 from 12